Definium Therapeutics Inc. Common Shares vs Elevance Health Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.54 (market cap $4.59B), while Elevance Health Inc. Common Stock trades at $416.61 (market cap $86.95B). The key difference: Elevance Health Inc. Common Stock is far larger — about 18.9× Definium Therapeutics Inc. Common Shares's market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals.
| DFTX | ELV | |
|---|---|---|
Market Cap | $4.59B | $86.95B |
Volume | 2,103,937 | 782,706 |
Sector | Health | Health |
52-Week High | $48.45 | $426.79 |
52-Week Low | $10.68 | $280.74 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $3.55B | $107.76B |
Dividend Yield | — | 1.72% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →